Could 3 radiation doses beat 4 for cervical cancer?

NCT ID NCT07022470

Recruiting now Disease control Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a shorter course of brachytherapy (3 sessions) to the standard 4-session regimen for locally advanced cervical cancer. About 41 participants will receive either 3 or 4 high-dose radiation treatments based on what is feasible for them. The goal is to see if the shorter schedule is practical and still controls the disease effectively.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation (brachytherapy)
What this could lead to: If successful, this could show that fewer radiation sessions are enough to control cervical cancer, making treatment shorter and more convenient.
What could go wrong: This is a small, early-phase trial with only 41 participants, so results may not apply to everyone. The 3-fraction schedule might not control the cancer as well as the standard 4-fraction regimen.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCERS

Contacts and locations

Locations

Stanford University
RECRUITING

Palo Alto, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.